BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31815634)

  • 1. Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study.
    Bromage DI; Godec TR; Pujades-Rodriguez M; Gonzalez-Izquierdo A; Denaxas S; Hemingway H; Yellon DM
    Cardiovasc Diabetol; 2019 Dec; 18(1):168. PubMed ID: 31815634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study.
    Chen TH; Li YR; Chen SW; Lin YS; Sun CC; Chen DY; Mao CT; Wu M; Chang CH; Chu PH; Wu VC
    Cardiovasc Diabetol; 2020 Nov; 19(1):189. PubMed ID: 33167990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.
    Paolisso P; Bergamaschi L; Gragnano F; Gallinoro E; Cesaro A; Sardu C; Mileva N; Foà A; Armillotta M; Sansonetti A; Amicone S; Impellizzeri A; Esposito G; Morici N; Andrea OJ; Casella G; Mauro C; Vassilev D; Galie N; Santulli G; Marfella R; Calabrò P; Pizzi C; Barbato E
    Pharmacol Res; 2023 Jan; 187():106597. PubMed ID: 36470546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure.
    Godec TR; Bromage DI; Pujades-Rodriguez M; Cannatà A; Gonzalez-Izquierdo A; Denaxas S; Hemingway H; Shah AM; Yellon DM; McDonagh TA
    ESC Heart Fail; 2022 Jun; 9(3):1608-1615. PubMed ID: 35322592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous use of metformin on cardiovascular outcomes in patients with type 2 diabetes after acute myocardial infarction: A protocol for systematic review and meta-analysis.
    Shen C; Tan S; Yang J
    Medicine (Baltimore); 2021 Apr; 100(15):e25353. PubMed ID: 33847633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus.
    Lyu YS; Oh S; Kim JH; Kim SY; Jeong MH
    Cardiovasc Diabetol; 2023 Jul; 22(1):185. PubMed ID: 37481509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Early SGLT2 Inhibitors Initiation in Diabetic Patients Following Acute Myocardial Infarction, a Retrospective Study.
    Moady G; Yakubovich I; Atar S
    J Cardiovasc Pharmacol Ther; 2024; 29():10742484241252474. PubMed ID: 38711298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial.
    Ritsinger V; Hagström E; Hambraeus K; James S; Jernberg T; Lagerqvist B; Leosdottir M; Lundman P; Pernow J; Östlund O; Norhammar A
    J Diabetes Complications; 2023 Oct; 37(10):108599. PubMed ID: 37683518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin Use in Type 2 Diabetics and Delirium After Noncardiac Surgery: A Retrospective Cohort Analysis.
    Paredes S; Harb A; Rössler J; Nikoo MZ; Ruetzler K; Turan A; Pu X; Sessler DI
    Anesth Analg; 2024 Jun; 138(6):1304-1312. PubMed ID: 38517762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pre-stroke metformin use on clinical outcomes after acute ischemic stroke: A systematic review and meta-analysis.
    Pakkam M; Orscelik A; Musmar B; Tolba H; Ghozy S; Senol YC; Bilgin C; Nayak SS; Kadirvel R; Brinjikji W; Rabinstein AA; Kallmes DF
    J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107716. PubMed ID: 38604350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design.
    Yen FS; Chen W; Wei JC; Hsu CC; Hwu CM
    PLoS One; 2018; 13(10):e0204859. PubMed ID: 30286138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myocardial infarction hospital admissions and deaths in England: a national follow-back and follow-forward record-linkage study.
    Asaria P; Elliott P; Douglass M; Obermeyer Z; Soljak M; Majeed A; Ezzati M
    Lancet Public Health; 2017 Apr; 2(4):e191-e201. PubMed ID: 29253451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.
    Oh TK; Song IA
    Acta Diabetol; 2021 Jun; 58(6):771-778. PubMed ID: 33582839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002-2014).
    de Miguel-Yanes JM; Jiménez-García R; Hernández-Barrera V; Méndez-Bailón M; de Miguel-Díez J; Lopez-de-Andrés A
    Cardiovasc Diabetol; 2017 Oct; 16(1):126. PubMed ID: 29017514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin treatment is associated with improved survival in diabetic patients hospitalized with acute heart failure: A prospective observational study using the Korean acute heart failure registry data.
    Chun KH; Oh J; Lee CJ; Park JJ; Lee SE; Kim MS; Cho HJ; Choi JO; Lee HY; Hwang KK; Kim KH; Yoo BS; Choi DJ; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Kang SM
    Diabetes Metab; 2024 Jan; 50(1):101504. PubMed ID: 38097010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence and mechanism of sodium-glucose cotransporter-2 inhibitors on the cardiac function: study protocol for a prospective cohort study.
    Cao MJ; Shi FH; Yu BB; Ma XC; Zhang C; Xu L; Jiang YH; Ge H; Shen L; Pu J
    Front Endocrinol (Lausanne); 2023; 14():1199960. PubMed ID: 37538793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction.
    Li YR; Tsai SS; Lin YS; Chung CM; Chen ST; Sun JH; Liou MJ; Chen TH
    Diabetol Metab Syndr; 2017; 9():71. PubMed ID: 28932290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of metformin in patients with type 2 diabetes mellitus and acute heart failure: Combined analysis of the EAHFE and RICA registries.
    Povar-Echeverría M; Méndez-Bailón M; Martín-Sánchez FJ; Montero-Pérez-Barquero M; Trullàs JC; Miró Ò
    Rev Clin Esp (Barc); 2023 Nov; 223(9):542-551. PubMed ID: 37717921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of early mortality and cardiovascular disease according to the presence of recently diagnosed diabetes and requirement for insulin treatment: A nationwide study.
    Lee YB; Han K; Kim B; Choi MS; Park J; Kim M; Jin SM; Hur KY; Kim G; Kim JH
    J Diabetes Investig; 2021 Oct; 12(10):1855-1863. PubMed ID: 33662172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study.
    Herrett E; Shah AD; Boggon R; Denaxas S; Smeeth L; van Staa T; Timmis A; Hemingway H
    BMJ; 2013 May; 346():f2350. PubMed ID: 23692896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.